These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 15235609)

  • 1. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.
    Hamamoto R; Furukawa Y; Morita M; Iimura Y; Silva FP; Li M; Yagyu R; Nakamura Y
    Nat Cell Biol; 2004 Aug; 6(8):731-40. PubMed ID: 15235609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis.
    Brown MA; Foreman K; Harriss J; Das C; Zhu L; Edwards M; Shaaban S; Tucker H
    Oncotarget; 2015 Feb; 6(6):4005-19. PubMed ID: 25738358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
    Kunizaki M; Hamamoto R; Silva FP; Yamaguchi K; Nagayasu T; Shibuya M; Nakamura Y; Furukawa Y
    Cancer Res; 2007 Nov; 67(22):10759-65. PubMed ID: 18006819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription.
    Kim H; Heo K; Kim JH; Kim K; Choi J; An W
    J Biol Chem; 2009 Jul; 284(30):19867-77. PubMed ID: 19509295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells.
    Zhang XD; Huang GW; Xie YH; He JZ; Guo JC; Xu XE; Liao LD; Xie YM; Song YM; Li EM; Xu LY
    Nucleic Acids Res; 2018 Feb; 46(4):1793-1809. PubMed ID: 29253179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells.
    Silva FP; Hamamoto R; Kunizaki M; Tsuge M; Nakamura Y; Furukawa Y
    Oncogene; 2008 Apr; 27(19):2686-92. PubMed ID: 17998933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells.
    Luo XG; Zou JN; Wang SZ; Zhang TC; Xi T
    IUBMB Life; 2010 Mar; 62(3):194-9. PubMed ID: 20039369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.
    Zhang H; Zheng Z; Zhang R; Yan Y; Peng Y; Ye H; Lin L; Xu J; Li W; Huang P
    Cell Death Dis; 2021 Jul; 12(8):731. PubMed ID: 34301921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation.
    Van Aller GS; Reynoird N; Barbash O; Huddleston M; Liu S; Zmoos AF; McDevitt P; Sinnamon R; Le B; Mas G; Annan R; Sage J; Garcia BA; Tummino PJ; Gozani O; Kruger RG
    Epigenetics; 2012 Apr; 7(4):340-3. PubMed ID: 22419068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smyd3-associated regulatory pathways in cancer.
    Giakountis A; Moulos P; Sarris ME; Hatzis P; Talianidis I
    Semin Cancer Biol; 2017 Feb; 42():70-80. PubMed ID: 27554136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
    Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.
    Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J
    BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone methyltransferase Smyd3 regulates early embryonic lineage commitment in mice.
    Suzuki S; Nozawa Y; Tsukamoto S; Kaneko T; Imai H; Minami N
    Reproduction; 2015 Jul; 150(1):21-30. PubMed ID: 25918436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced SMYD3 expression is essential for the growth of breast cancer cells.
    Hamamoto R; Silva FP; Tsuge M; Nishidate T; Katagiri T; Nakamura Y; Furukawa Y
    Cancer Sci; 2006 Feb; 97(2):113-8. PubMed ID: 16441421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of SMYD3 by hepatitis B virus X gene in HepG2 cells].
    Yang L; Ren J; He J; Chen LB
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):297-300. PubMed ID: 19403031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
    Wang Y; Xie BH; Lin WH; Huang YH; Ni JY; Hu J; Cui W; Zhou J; Shen L; Xu LF; Lian F; Li HP
    Oncogene; 2019 Jun; 38(25):4948-4961. PubMed ID: 30842588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells.
    Luo XG; Zhang CL; Zhao WW; Liu ZP; Liu L; Mu A; Guo S; Wang N; Zhou H; Zhang TC
    Cancer Lett; 2014 Mar; 344(1):129-137. PubMed ID: 24189459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration.
    Chen LB; Xu JY; Yang Z; Wang GB
    World J Gastroenterol; 2007 Nov; 13(43):5718-24. PubMed ID: 17963297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.